APA (7th ed.) Citation

Yvyin Zhang, Peihong Wang, Yang Wang, & Yang Shen. (2023). Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia. BMC.

Chicago Style (17th ed.) Citation

Yvyin Zhang, Peihong Wang, Yang Wang, and Yang Shen. Sitravatinib as a Potent FLT3 Inhibitor Can Overcome Gilteritinib Resistance in Acute Myeloid Leukemia. BMC, 2023.

MLA (9th ed.) Citation

Yvyin Zhang, et al. Sitravatinib as a Potent FLT3 Inhibitor Can Overcome Gilteritinib Resistance in Acute Myeloid Leukemia. BMC, 2023.